Sophion Bioscience Collaborates with Merck
News Dec 21, 2005
Sophion Bioscience, Inc. and Sophion Bioscience A/S (Ballerup, Denmark) have announced collaboration with Merck & Co., Inc. to complete the QPatch HT, a 48-channel automated, gigaseal patch clamp system.
QPatch HT is a second-generation instrument based on the QPatch 16, a 16-channel automated patch clamp system marketed by Sophion and in use at pharmaceutical and biotech companies around the world for hERG testing, ion channel screening and drug discovery programs.
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019